2017
DOI: 10.18632/oncotarget.15336
|View full text |Cite
|
Sign up to set email alerts
|

Activation of JNK and IRE1 is critically involved in tanshinone I-induced p62 dependent autophagy in malignant pleural mesothelioma cells: implication of p62 UBA domain

Abstract: The aim of present study is to elucidate autophagic mechanism of tanshinone I (Tan I) in H28 and H2452 mesothelioma cells. Herein, Tan I exerted cytotoxicity with autophagic features of autophagy protein 5 (ATG5)/ microtubule-associated protein 1A/1B-light chain 3II (LC3 II) activation, p62/sequestosome 1 (SQSTM1) accumulation and increased number of LC3II punctae, acridine orange-stained cells and autophagic vacuoles. However, 3-methyladenine (3MA) and NH4Cl increased cytotoxicity in Tan I treated H28 cells. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
18
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(19 citation statements)
references
References 41 publications
(42 reference statements)
1
18
0
Order By: Relevance
“…2) is a derivative of phenanthrenequinone isolated from the dried root or rhizomes of Salvia miltiorrhiza Bunge. Tanshinone IIA is the primary bioactive constituent of tanshinones [502], which has various pharmacological effects, including anti-inflammatory, anti-cancer and anti-atherosclerotic activities, and cardiovascular protection [503][504][505][506]. Tanshinone exhibits anti-cancer activities in stomach, prostate, lung, breast, and colon cancers, through inducing cell cycle arrest, apoptosis, autophagy, and inhibiting cell migration [507][508][509][510][511][512][513][514][515].…”
Section: Tanshinonesmentioning
confidence: 99%
See 1 more Smart Citation
“…2) is a derivative of phenanthrenequinone isolated from the dried root or rhizomes of Salvia miltiorrhiza Bunge. Tanshinone IIA is the primary bioactive constituent of tanshinones [502], which has various pharmacological effects, including anti-inflammatory, anti-cancer and anti-atherosclerotic activities, and cardiovascular protection [503][504][505][506]. Tanshinone exhibits anti-cancer activities in stomach, prostate, lung, breast, and colon cancers, through inducing cell cycle arrest, apoptosis, autophagy, and inhibiting cell migration [507][508][509][510][511][512][513][514][515].…”
Section: Tanshinonesmentioning
confidence: 99%
“…Furthermore, tanshinone IIA induces autophagy to inhibit cell growth in human osteosarcoma 143B and MG63 cells and tumor growth in NOD/SCID mice [526], while it induces autophagy to mediate anticancer activities through activating beclin-1 pathway and inhibiting PI3K/Akt/mTOR pathway in human oral squamous cell carcinoma SCC-9, melanoma A375, and glioma U251 cells [527][528][529]. Moreover, tanshinone IIA is shown to exhibit anti-cancer activities through the interplay between autophagy and apoptosis in human prostate cancer PC-3 cells, mesothelioma H28 and H2452 cells [502,530].…”
Section: Tanshinonesmentioning
confidence: 99%
“…In A375 cells, TA IIA inhibits the proliferation of A375 cells by activating the autophagy pathway [36]. However, Lee et al revealed that TA I induces protective autophagy in malignant pleural mesothelioma cells [37]. Jing et al also revealed that TA I induces pro-survival autophagy in gastric cancers [4].…”
Section: Discussionmentioning
confidence: 99%
“…For example, activation of Jun N-terminal kinase (JNK) was shown to induce p62 mRNA expression [24,25]. In addition, two groups recently reported that inositol-requiring enzyme 1 alpha (IRE1α)/JNK signaling associated with endoplasmic reticulum (ER) stress augments p62 expression [26,27].…”
Section: Introductionmentioning
confidence: 99%